Trials / Completed
CompletedNCT03953807
A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated
A 12-month, Prospective, Open-label, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Treatment Naïve Patients (According to Standard Clinical Practice) With Diabetic Macular Edema
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy and safety of OZURDEX in patients with Diabetic Macular Edema when used in a real world setting in Spain and Portugal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone Intravitreal Implant | Implant 700 μg |
Timeline
- Start date
- 2019-09-05
- Primary completion
- 2022-07-04
- Completion
- 2022-07-04
- First posted
- 2019-05-17
- Last updated
- 2022-10-07
Locations
26 sites across 2 countries: Portugal, Spain
Source: ClinicalTrials.gov record NCT03953807. Inclusion in this directory is not an endorsement.